Newsroom

[WSJ] New Costly Cancer Treatments Face Hurdles Getting to Patients

Cancer treatments that genetically modify patients’ blood cells to target the disease have shown amazing results in clinical trials. Now drug companies and biotechs must overcome big hurdles to get them into hospitals, including their potential cost.

Read more

[Forbes] ’60 Minutes’ Just Attacked High Drug Prices. Here’s What You Should Know.

60 Minutes, the most successful news program in American history, just took aim at the extraordinarily high ($100,000 per patient per year) prices charged for cancer […]

Read more

[WSJ] Lawmakers Probe ‘Staggering’ Price Hikes for Generic Drugs

In response to recent reports that the cost of some generic drugs has been unexpectedly rising at a rapid clip, two members of Congress have launched an investigation and asked 14 generic drug makers to providing data about what the lawmakers called the “escalating prices they have been charging” for generic medicines.

Read more

[MarketWatch] Sovaldi pricing raises debate over drug costs

With the California-based drug manufacturer Gilead Sciences planning to roll out another hepatitis C medication, academics said Wednesday that policy changes are needed in the costly drug market so the interests of patients, health insurers and pharmaceutical companies align.

Read more